Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin

BACKGROUND: Metformin is an oral antidiabetic drug (OAD) widely used as first-line therapy in type 2 diabetes (T2D) treatments. Numerous treatment pathways after metformin failure exist. It is important to understand how treatment choices influence subsequent therapy progressions. This retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xiaomei, Jiang, Dingfeng, Liu, Dongju, Varnado, Oralee J, Bae, Jay P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986679/
https://www.ncbi.nlm.nih.gov/pubmed/27570448
http://dx.doi.org/10.2147/PPA.S109664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986679/
https://www.ncbi.nlm.nih.gov/pubmed/27570448
http://dx.doi.org/10.2147/PPA.S109664

Ejemplares similares